nav-left cat-right
cat-right

Billionaire backs new program for a pioneering Alz...

German billionaire Dietmar Hopp is adding to his multimillion-dollar wager on AC Immune, the Swiss biotech that is playing a key role in some high-profile Alzheimer’s programs. Hopp has been the primary investor behind the company, and today he joined in a $22 million D round designed to fund a new therapeutic vaccine program aimed at the memory-wasting disease. AC Immune isn’t built like most biotechs. CEO Andrea...

Cancer Research UK will repurpose an AstraZeneca a...

Cancer Research UK has struck a deal with AstraZeneca ($AZN) to repurpose an experimental therapy originally developed by the drug giant for asthma and study its ability to fight kidney cancer. Under the agreement, the nonprofit’s drug development office will carry out preclinical testing and early clinical trials of the compound, AZD2098. Cancer Research UK plans to begin enrolling up to 40 patients in an early phase...

Alcohol-addicted rats treated with optogenetics st...

Using an emerging technique called optogenetics, which uses light to stimulate neurons, researchers at the University at Buffalo have found a way to alter alcohol drinking in rodents that mimics human binge drinking behavior. The investigators say the findings could help scientists develop new treatments for alcoholism, other addictions and neurological and mental illnesses. First, researchers trained rats to drink alcohol in...

Illumina’s New Sequencers

The genetics world was rocked by a surprise announcement from its most prominent company: Illumina is secretly owned by Apple. At least, that would explain the company’s obvious joy at making their previous products look obsolete, and the way their competitors have to constantly protest that, yes, Illumina’s latest gadget is obviously very cool, but wouldn’t you like to compare prices and specifications? (This theory...

Mechanical forces at work in living cells and tiss...

Don Ingber, of Harvard University’s Wyss Institute for Biologically Inspired Engineering, is a mechanobiologist – a member of the small but growing community of scientists who look at biological systems through the lens of physics. Mechanobiologists hope to add to our understanding of physiology, embryology, and disease ontogeny by observing the mechanical forces at work in living cells and tissues. Ingber sees this work...

Bill would fast-track promising antibiotics for FD...

The antibiotics arena hasn’t proved lucrative enough for Big Pharma, leading to a mass exodus from the field in recent years. But pharma companies may have a reason to get back in the antibiotics game. A group of bipartisan members in the House of Representatives introduced a bill late Thursday that aims to combat the growing threat of so-called “superbugs” by essentially providing a fast-track route to FDA...
Page 20 of 197« First...10...1819202122...304050...Last »